00.
Response Biomedical is a publicly traded company, listed on the TSX
under the trading symbol "RBM" and quoted on the OTC Bulletin Board under
the symbol "RPBIF". For further information, please visit the Company's
website at http://www.responsebio.com.
CONTACT: Response Biomedical Contacts: Bill Wickson, Manager, Investor
Relations, Response Biomedical Corporation, Tel (604) 456-6073, Email:
bwickson@responsebio.com; Brian Korb, Vice President, The Trout Group LLC,
Tel: (646) 378-2923, Email: bkorb@troutgroup.com
'/>"/>SOURCE Response Biomedical Corp. Copyright©2008 PR Newswire. All rights reserved | |
Page: 1 2 Related medicine news :1.
RNC RESPONSE TO OBAMA COMMENTS ON MEDICAL MARIJUANA LAWS2.
Passport Health Disaster Response Experts Offer Services to Myanmar Volunteers3.
Study identifies molecular response of cartilage to injury4.
Aspen Institute to Release Presidential Candidates Responses to Health Care Reform Questionnaire; New Zogby Poll Findings Also to be Released5.
Previously unseen switch regulates breast cancer response to estrogen6.
CNS Response, Inc.: Poster Session on Referenced-EEG Guided Medication to Be Presented at the American Psychiatric Association 161st Annual Meeting7.
CNS Response, Inc. Names William E. Bunney, Jr., MD to Scientific Advisory Board8.
CNS Response, Inc: rEEG(R) Research to be Presented at 38th National Council Conference9.
Largest Ever Regional AIDS Conference to Review Epidemic Status and Changing Challenges in the Response10.
Statement by H.E. Jakaya Mrisho Kikwete, President of the United Republic of Tanzania, and Chairman of the African Union, in Response to UN-SG Call to Action on Malaria11.
PCMA Response to New York Times Article on Biotech Medicine Costs